Current apparent treatment‐resistant hypertension in patients undergoing peritoneal dialysis: A multi‐center cross‐sectional study
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Apparent treatment-resistant hypertension (aTRH) is the most commonly used term to report resistant hypertension (RH) and is considered as a common problem in dialysis population. However, few reports have focused on peritoneal dialysis (PD) hypertensive patients. The authors conducted a multi-center cross-sectional study involving 1789 PD patients from nine centers in Guangdong, China. The prevalence of aTRH was estimated by home blood pressure (BP) monitoring. Evaluating drug adherence through Eight-item Morisky Medication Adherence Scale (MMAS-8) and pill counting was performed to assess RH in one PD center. Related factors of aTRH were analyzed using logistic regression analysis. The prevalence of aTRH in PD patients was estimated at 42.2% (755 out of 1789 hypertensive patients) based on home BP. Of those, 91.4% patients were classified as uncontrolled RH, 2.0% as controlled RH, and 6.6% as refractory hypertension. The prevalence of RH was 40.6% and 41.9% among those with medium/high adherence based on the MMAS-8 scores and the pill counting rate, respectively. PD patients who were younger, with higher body mass index, with lower serum albumin and poorer dialysis adequacy were significantly associated with higher aTRH incident. In conclusion, the present study demonstrates a high prevalence of aTRH in PD population, which occurs in about two in five treated hypertensive patients. Nutritional status and dialysis adequacy might tightly associate with aTRH.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Current apparent treatment‐resistant hypertension in patients undergoing peritoneal dialysis: A multi‐center cross‐sectional study
- Date Crossref
- 02/03/2022
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Nanfang Hospital pays non établi dans la noticeÉtablissement de santé
-
Southern Medical University State Key Laboratory of Organ Failure Research pays non établi dans la noticeUniversité ou école supérieure
-
First People's Hospital of Foshan Nephrology Department pays non établi dans la noticeÉtablissement de santé
-
Third Affiliated Hospital of Southern Medical University pays non établi dans la noticeÉtablissement de santé
-
Sun Yat-sen University Department of Nephrology pays non établi dans la noticeUniversité ou école supérieure
-
Tung Wah Hospital pays non établi dans la noticeÉtablissement de santé
-
Jiangmen Central Hospital pays non établi dans la noticeÉtablissement de santé
-
Foshan Second People's Hospital pays non établi dans la noticeÉtablissement de santé
-
Fifth Affiliated Hospital of Sun Yat-sen University pays non établi dans la noticeÉtablissement de santé
-
The First People's Hospital of Shunde pays non établi dans la noticeÉtablissement de santé
-
Guangzhou University of Chinese Medicine Department of Nephrology pays non établi dans la noticeUniversité ou école supérieure
-
School of Nursing pays non établi dans la noticeUniversité ou école supérieure
Nanfang Hospital, State Key Laboratory of Organ Failure Research — Southern Medical University et Nephrology Department — First People's Hospital of Foshan, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.